Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2004
09/16/2004US20040180943 Oxazolone analogs as amyloid aggregation inhibitors and for the treatment of alzheimer's disease and disorders related to amyloidosis
09/16/2004US20040180935 in a solid dosage form for oral administration, such as a tablet; preventing or treating a disease that is associated with excess gastric acid secretion
09/16/2004US20040180927 Inhibitors of cysteine protease
09/16/2004US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate
09/16/2004US20040180923 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction
09/16/2004US20040180914 5-Cyano-2-aminopyrimidine derivatives
09/16/2004US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable
09/16/2004US20040180906 Anti-inflammatory medicaments
09/16/2004US20040180905 for treating cancer and fibrotic diseases
09/16/2004US20040180902 3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
09/16/2004US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
09/16/2004US20040180899 tyrosine kinase inhibitors
09/16/2004US20040180896 P38 inhibitors and methods of use thereof
09/16/2004US20040180894 Benzamide inhibitors of the P2X7 receptor
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/16/2004US20040180891 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
09/16/2004US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists
09/16/2004US20040180885 Indole derivatives, process for preparation of the same and use thereof
09/16/2004US20040180882 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/16/2004US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
09/16/2004US20040180874 5-HT6 modulators; such as 2-benzenesulfonyl-5-piperazin-1-yl-1,2,3,4-tetrahydroisoquinoline;
09/16/2004US20040180841 Enhanced cancer selectivity; compounds having at least one hydroxyl group replaced with alternate functionality
09/16/2004US20040177804 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
09/16/2004DE102004010086A1 Substiuierte Piperidinderivate Substiuierte piperidine
09/16/2004CA2518322A1 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof
09/16/2004CA2517844A1 Quinazolines useful as modulators of ion channels
09/16/2004CA2517166A1 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists
09/16/2004CA2517146A1 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
09/16/2004CA2517088A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
09/16/2004CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
09/16/2004CA2516624A1 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
09/16/2004CA2513652A1 G-lactam derivatives as prostaglandin agonists
09/16/2004CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof
09/15/2004EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity
09/15/2004EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity
09/15/2004EP1457199A1 Coupling agents having a 2,3,5-triaminopyridine structure and their use for dyeing keratinic fibres
09/15/2004EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme
09/15/2004EP1456200A1 Lactams as tachykinin antagonists
09/15/2004EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
09/15/2004EP1456198A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
09/15/2004EP1456197A1 Piperidine-2,6-diones that are heterocyclically substituted in position 3
09/15/2004EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
09/15/2004EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer
09/15/2004EP1456178A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
09/15/2004EP1456175A1 Substituted heterocyclic carboxamides with antithrombotic activity
09/15/2004EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors
09/15/2004EP1455791A1 Method for administering birb 796 bs
09/15/2004EP1455788A1 1-glycinyl-4-aminomethyl-piperidine derivatives as factor xa inhibitors
09/15/2004EP1455787A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1455579A1 Pyrazoles-pyrimidine fungicides
09/15/2004EP1368338A4 Method of preparing lansoprazole and its intermediate
09/15/2004EP1363902B1 Chemical compounds
09/15/2004EP1349849B1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
09/15/2004EP1295878B1 Pyrazinone derivatives
09/15/2004EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
09/15/2004EP1196408B1 Respiratory syncytial virus replication inhibitors
09/15/2004EP1019398B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/15/2004EP1001774B1 Use of phospholamban inhibitors for increasing coronary flow
09/15/2004EP0993460B1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/15/2004EP0990653B1 2-oxoimidazole derivatives
09/15/2004EP0983054B1 Hair growth compositions and uses
09/15/2004CN1529703A 新的吲哚衍生物 The new indole derivatives
09/15/2004CN1529699A Novel sulfonic acid derivatives
09/15/2004CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same
09/15/2004CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative
09/15/2004CN1529598A Method of treating demyelinating diseases or conditions
09/15/2004CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic
09/15/2004CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate
09/15/2004CN1166665C Arylpiperidine derivatives and use thereof
09/15/2004CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof
09/15/2004CN1166643C 4-phenyl-pyrimidine derivatives
09/15/2004CN1166641C New cycloheplene compound, its preparation method and medicine composition containing same
09/15/2004CN1166639C Antimalarial quinolin derivatives, its preparation and use
09/15/2004CN1166636C Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
09/15/2004CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same
09/14/2004US6790860 Pyrrolidine derivatives
09/14/2004US6790858 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
09/14/2004US6790845 Having an attached non-aromatic heterocyclic ring
09/14/2004US6790844 Muscle relaxants; antiserotonine agent
09/14/2004US6790597 Rapid cure, stable to elevated temperatures, are highly flexible, have low moisture uptake
09/14/2004CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
09/14/2004CA2212007C Pyridonecarboxylic acid derivatives substitued by a bicyclic amino group
09/10/2004WO2004076457A1 Solvent-free process for the preparation of pyrrolo (3,4c) pyrrole compounds
09/10/2004WO2004076456A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
09/10/2004WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound
09/10/2004WO2004076434A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076433A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076429A1 Ethynyl derivatives serving as factor xa inhibitors
09/10/2004WO2004076424A1 Heterocyclic kinase inhibitors
09/10/2004WO2004076421A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004076419A1 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
09/10/2004WO2004076418A1 Ligands that modulate lxr-type receptors
09/10/2004WO2004076413A2 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
09/10/2004WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004WO2004076053A2 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
09/10/2004WO2004075898A1 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury
09/10/2004WO2004075863A2 Cxcr3 antagonists
09/10/2004WO2004075840A2 Selective non-steroidal glucocorticoid receptor modulators